MEDIGENE

Welcome to the Brand page for “MEDIGENE”, which is offered here for Services in the field of molecular biology, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds and tumor antigens with pharmaceutical properties; development of test methods and test kits in the field of molecular biology; development of adoptive t cell therapy; development of dc vaccines; development of cellular tumor therapy; development of tumor markers; development of diagnostic and therapeutic antibodies; genetic and biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific purposes;.

Its status is currently believed to be active. Its class is unavailable. “MEDIGENE” is believed to be currently owned by “MEDIGENE AG”.


Owner:
MEDIGENE AG
Owner Details
Description:
Services in the field of molecular biology, research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds and tumor antigens with pharmaceutical properties; development of test methods and test kits in the field of molecular biology; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumor therapy; development of tumor markers; development of diagnostic and therapeutic antibodies; genetic and biological cell analyses; development of individualized medicine, development of treatment plans and therapy adapted for individual patients; all the foregoing being for scientific purposes;
Categories: SERVICES FIELD